Cargando…
HER2 expression in urothelial carcinoma, a systematic literature review
BACKGROUND: Urothelial carcinoma (UC) is a common malignancy with significant associated mortality. Recent clinical trials suggest an emerging role for HER2-targeted therapy. Testing for HER2 expression in UC is not part of current routine clinical practice. In consequence, the prevalence of HER2 ex...
Autores principales: | Scherrer, Emilie, Kang, Ashley, Bloudek, Lisa M., Koshkin, Vadim S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635895/ https://www.ncbi.nlm.nih.gov/pubmed/36338710 http://dx.doi.org/10.3389/fonc.2022.1011885 |
Ejemplares similares
-
Head-to-Head Comparison of the Expression Differences of NECTIN-4, TROP-2, and HER2 in Urothelial Carcinoma and Its Histologic Variants
por: Fan, Yu, et al.
Publicado: (2022) -
Treatment options for advanced urothelial cancer after progression on chemotherapy and immune checkpoint inhibitors: a literature review
por: Koshkin, Vadim S., et al.
Publicado: (2021) -
Papillary urothelial carcinoma of the vagina: A case presentation and review of the literature
por: Razdan, Shirin, et al.
Publicado: (2019) -
The role of avelumab in advanced urothelial carcinoma in the context of a dynamic treatment landscape
por: Koshkin, Vadim S., et al.
Publicado: (2019) -
Nodular cutaneous metastasis of the leg in advanced urothelial bladder carcinoma: a case report and systematic literature review
por: Izzo, Paolo, et al.
Publicado: (2023)